Both type 1 and type 2 diabetes do more than raise blood sugar. They also trigger chronic inflammation, which can disrupt the neuroimmune axis, the communication network between the nervous and immune systems. Electroceuticals that stimulate the autonomic nervous system could help bring this inflammation under control. However, existing systems lack a way to sense the body’s metabolism in real time and use that feedback to restore the balance between the immune and metabolic systems. Also, they need external batteries or wireless charging to run.